Article Text
Abstract
Leukoaraiosis describes diffuse white matter abnormalities on CT or MR brain scans, often seen in the normal elderly and in association with vascular risk factors such as hypertension, or in the context of cognitive impairment. The term was introduced to avoid confusing an imaging appearance with a specific pathology. Neurologists often come across this appearance, but its significance is sometimes uncertain. The effects on cognitive function and gait are insidious and can be difficult to detect at the bedside, but are nevertheless important. However, gradually it is becoming clearer how leukoaraiosis relates to cerebrovascular disease, Alzheimer’s and other diseases, and how this appearance should influence treatment decisions.
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
- Investigation of hypertensive arteriopathy-related and cerebral amyloid angiopathy-related small vessel disease scores in patients from a memory clinic: a prospective single-centre study
- Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum
- Age-related cerebral white matter disease (leukoaraiosis): a review
- The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
- In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease
- Neuroimaging in dementia: a practical guide
- White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging
- Cerebellar atrophy and its implications on gait in cerebral amyloid angiopathy
- Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: a 6-year longitudinal study in patients with type 2 diabetes mellitus